ClinicalTrials.Veeva

Menu
A

Altus Research | Women's Health Studies

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Elagolix
Estradiol
Fluconazole
Mesafem
VT-1161
fezolinetant
Norethindrone Acetate
SCY-078
Bimagrumab
Tirzepatide

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 70 total trials

A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight

The main purpose of this study is to evaluate the efficacy and safety of Bimagrumab and Tirzepatide, alone or in combination, in adults with obesity...

Enrolling
Overweight
Obesity
Drug: Tirzepatide Placebo
Drug: Bimagrumab

The primary objective of this study is to assess the effect of enobosarm on total lean mass as measured by DEXA in patients maintained on GLP-1 recep...

Active, not recruiting
Obesity
Muscle Loss
Drug: Semaglutide
Drug: Enobosarm

This study will be in two parts, Part A and Part B. The primary objective of Part A is to evaluate the contraceptive efficacy of LPRI-CF113. The seco...

Active, not recruiting
Contraception
Change in Bone Mineral Density
Drug: Drospirenone

To assess the contraceptive efficacy (prevention of pregnancy) of VeraCept

Active, not recruiting
Women at Risk for Pregnancy
Drug: VeraCept

Prospective, multi-center, international, non-randomized, two-arm study of subjects undergoing either FemBloc or laparoscopic bilateral tubal sterili...

Active, not recruiting
Contraception
Device: FemBloc
Procedure: Laparoscopic bilateral tubal sterilization

A phase 2 study to assess the efficacy of bimagrumab alone or in addition to semaglutide to assess efficacy and safety in overweight or obese men and...

Active, not recruiting
Overweight or Obesity
Obese
Drug: Semaglutide
Biological: Bimagrumab

The Sponsor is developing a progestin-only contraceptive transdermal system (patch).The main purpose of this study is to look at how safe the study p...

Enrolling
Female Contraception
Drug: Transdermal system containing progestin

Trial sponsors

Pfizer logo
AbbVie logo
Astellas logo
Lilly logo
Amgen logo
Bayer logo
C
E
F
Inovio Pharmaceuticals logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems